NYSE: AORT

Artivion Inc Stock Forecast, Predictions & Price Target

The consensus among 2 Wall Street analysts covering (NYSE: AORT) stock is to Strong Buy AORT stock.

Out of 2 analysts, 1 (50%) are recommending AORT as a Strong Buy, 1 (50%) are recommending AORT as a Buy, 0 (0%) are recommending AORT as a Hold, 0 (0%) are recommending AORT as a Sell, and 0 (0%) are recommending AORT as a Strong Sell.

If you're new to stock investing, here's how to buy Artivion stock.

(NYSE: AORT) Artivion's forecast annual revenue growth rate of 10.19% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.61%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.23%.

Artivion's revenue in 2024 is $354,004,000.On average, 2 Wall Street analysts forecast AORT's revenue for 2024 to be $16,032,456,168, with the lowest AORT revenue forecast at $15,987,108,516, and the highest AORT revenue forecast at $16,077,803,820. On average, 2 Wall Street analysts forecast AORT's revenue for 2025 to be $17,605,195,183, with the lowest AORT revenue forecast at $17,524,806,164, and the highest AORT revenue forecast at $17,685,584,202.

In 2026, AORT is forecast to generate $19,573,695,522 in revenue, with the lowest revenue forecast at $19,573,695,522 and the highest revenue forecast at $19,573,695,522.

According to 2 Wall Street analysts that have issued a 1 year AORT price target, the average AORT price target is $23.50, with the highest AORT stock price forecast at $25.00 and the lowest AORT stock price forecast at $22.00.

On average, Wall Street analysts predict that Artivion's share price could reach $23.50 by Apr 8, 2025. The average Artivion stock price prediction forecasts a potential upside of 12.33% from the current AORT share price of $20.92.

(NYSE: AORT) forecast ROE is N/A, which is considered weak.